Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

Joris L. Vos(Memorial Sloan Kettering Cancer Center), Charlotte L. Zuur(Leiden University Medical Center)
Nature Communications
December 22, 2021
Cited by 330


Related Papers

No related papers found

Powered by citation graph analysis